A detailed history of Schonfeld Strategic Advisors LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 190,800 shares of LUNG stock, worth $1.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
190,800
Holding current value
$1.19 Million
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.59 - $8.58 $1.07 Million - $1.64 Million
190,800 New
190,800 $1.58 Million
Q1 2023

May 15, 2023

SELL
$7.49 - $12.54 $281,878 - $471,930
-37,634 Reduced 59.55%
25,566 $285,000
Q4 2022

Feb 14, 2023

BUY
$4.92 - $17.35 $310,944 - $1.1 Million
63,200 New
63,200 $532,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $233M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.